Orient Pharma Co., Ltd. (TPEX:4166)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
25.70
+2.30 (9.83%)
Sep 5, 2025, 1:23 PM CST

Orient Pharma Statistics

Total Valuation

Orient Pharma has a market cap or net worth of TWD 5.73 billion. The enterprise value is 5.95 billion.

Market Cap5.73B
Enterprise Value 5.95B

Important Dates

The last earnings date was Wednesday, August 13, 2025.

Earnings Date Aug 13, 2025
Ex-Dividend Date n/a

Share Statistics

Orient Pharma has 223.04 million shares outstanding. The number of shares has decreased by -1.00% in one year.

Current Share Class 223.04M
Shares Outstanding 223.04M
Shares Change (YoY) -1.00%
Shares Change (QoQ) +5.22%
Owned by Insiders (%) 2.08%
Owned by Institutions (%) n/a
Float 35.22M

Valuation Ratios

The trailing PE ratio is 71.60.

PE Ratio 71.60
Forward PE n/a
PS Ratio 4.54
PB Ratio 3.09
P/TBV Ratio 4.05
P/FCF Ratio 24.45
P/OCF Ratio 22.51
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.43, with an EV/FCF ratio of 25.39.

EV / Earnings 74.68
EV / Sales 4.72
EV / EBITDA 21.43
EV / EBIT 41.24
EV / FCF 25.39

Financial Position

The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.23.

Current Ratio 1.76
Quick Ratio 0.97
Debt / Equity 0.23
Debt / EBITDA 1.56
Debt / FCF 1.85
Interest Coverage 11.70

Financial Efficiency

Return on equity (ROE) is 4.39% and return on invested capital (ROIC) is 3.82%.

Return on Equity (ROE) 4.39%
Return on Assets (ROA) 3.50%
Return on Invested Capital (ROIC) 3.82%
Return on Capital Employed (ROCE) 6.96%
Revenue Per Employee 7.30M
Profits Per Employee 460,740
Employee Count 173
Asset Turnover 0.49
Inventory Turnover 1.99

Taxes

In the past 12 months, Orient Pharma has paid 44.97 million in taxes.

Income Tax 44.97M
Effective Tax Rate 36.07%

Stock Price Statistics

The stock price has decreased by -2.10% in the last 52 weeks. The beta is -0.02, so Orient Pharma's price volatility has been lower than the market average.

Beta (5Y) -0.02
52-Week Price Change -2.10%
50-Day Moving Average 32.46
200-Day Moving Average 34.57
Relative Strength Index (RSI) 37.83
Average Volume (20 Days) 560,070

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Orient Pharma had revenue of TWD 1.26 billion and earned 79.71 million in profits. Earnings per share was 0.36.

Revenue1.26B
Gross Profit 664.60M
Operating Income 144.34M
Pretax Income 124.68M
Net Income 79.71M
EBITDA 258.14M
EBIT 144.34M
Earnings Per Share (EPS) 0.36
Full Income Statement

Balance Sheet

The company has 212.58 million in cash and 432.98 million in debt, giving a net cash position of -220.41 million or -0.99 per share.

Cash & Cash Equivalents 212.58M
Total Debt 432.98M
Net Cash -220.41M
Net Cash Per Share -0.99
Equity (Book Value) 1.86B
Book Value Per Share 7.91
Working Capital 361.43M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 254.60 million and capital expenditures -20.16 million, giving a free cash flow of 234.44 million.

Operating Cash Flow 254.60M
Capital Expenditures -20.16M
Free Cash Flow 234.44M
FCF Per Share 1.05
Full Cash Flow Statement

Margins

Gross margin is 52.65%, with operating and profit margins of 11.43% and 6.31%.

Gross Margin 52.65%
Operating Margin 11.43%
Pretax Margin 9.88%
Profit Margin 6.31%
EBITDA Margin 20.45%
EBIT Margin 11.43%
FCF Margin 18.57%

Dividends & Yields

Orient Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 1.00%
Shareholder Yield n/a
Earnings Yield 1.39%
FCF Yield 4.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 23, 2016. It was a reverse split with a ratio of 0.6500936135.

Last Split Date May 23, 2016
Split Type Reverse
Split Ratio 0.6500936135

Scores

Altman Z-Score n/a
Piotroski F-Score 7